FIL Ltd Has $94.90 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

FIL Ltd decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 181,805 shares of the medical equipment provider’s stock after selling 18,138 shares during the period. FIL Ltd’s holdings in Intuitive Surgical were worth $94,895,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of ISRG. Vanguard Group Inc. grew its stake in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC grew its stake in Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after buying an additional 243,802 shares during the last quarter. Fisher Asset Management LLC grew its stake in Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after buying an additional 86,488 shares during the last quarter. Norges Bank acquired a new position in Intuitive Surgical in the 4th quarter valued at $2,401,493,000. Finally, Invesco Ltd. grew its stake in Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after buying an additional 295,025 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 14.3 %

Shares of ISRG stock opened at $522.95 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $186.26 billion, a P/E ratio of 81.58, a P/E/G ratio of 5.85 and a beta of 1.55. The firm has a 50-day moving average price of $536.22 and a 200 day moving average price of $532.26.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Bernstein Bank increased their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.